Free Trial
NASDAQ:ASLN

ASLAN Pharmaceuticals (ASLN) Stock Price, News & Analysis

ASLAN Pharmaceuticals logo
$0.60 0.00 (0.00%)
As of 07/1/2025

About ASLAN Pharmaceuticals Stock (NASDAQ:ASLN)

Key Stats

Today's Range
$0.60
$0.60
50-Day Range
$0.60
$0.60
52-Week Range
$0.48
$25.44
Volume
N/A
Average Volume
122,322 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ASLN Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

ASLN Stock Analysis - Frequently Asked Questions

ASLAN Pharmaceuticals' stock was trading at $0.60 at the beginning of 2025. Since then, ASLN shares have increased by 0.0% and is now trading at $0.60.
View the best growth stocks for 2025 here
.

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) issued its quarterly earnings results on Friday, August, 11th. The company reported ($0.88) EPS for the quarter, topping analysts' consensus estimates of ($6.40) by $5.52. The firm earned $12 million during the quarter.

ASLAN Pharmaceuticals's stock reverse split before market open on Wednesday, July 3rd 2024.The 1-8 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

ASLAN Pharmaceuticals (ASLN) raised $60 million in an IPO on Friday, May 4th 2018. The company issued 7,500,000 shares at $8.05 per share. Leerink Partners and Piper Jaffray acted as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

Shares of ASLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ASLAN Pharmaceuticals investors own include Tesla (TSLA), Sorrento Therapeutics (SRNE), Bionano Genomics (BNGO), Meta Platforms (META), Zoom Communications (ZM), Fulgent Genetics (FLGT) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
8/11/2023
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASLN
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.22 million
Pretax Margin
-290.83%

Debt

Sales & Book Value

Annual Sales
$12 million
Price / Cash Flow
N/A
Book Value
($6.50) per share
Price / Book
-0.09

Miscellaneous

Free Float
1,948,000
Market Cap
$1.23 million
Optionable
Optionable
Beta
1.40
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ASLN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners